© 2020 MJH Life Sciences and OncLive. All rights reserved.
December 05, 2019
Sham Mailankody, MBBS, discusses research regarding the BCMA CAR T-cell therapy bb2121 in patients with relapsed/refractory multiple myeloma.
November 23, 2019
Sham Mailankody, MBBS, discusses minimal residual disease negativity in multiple myeloma.
November 06, 2019
Sham Mailankody, MBBS, discusses results of the CASSIOPEIA trial in patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.